Guilin Sanjin Pharmaceutical Co., Ltd. (SHE:002275)
China flag China · Delayed Price · Currency is CNY
14.27
-0.02 (-0.14%)
At close: Feb 3, 2026

SHE:002275 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Jan '23 Jan '22 Dec '20
Cash & Equivalents
1,0781,0501,0581,2661,4781,362
Short-Term Investments
--43.4--25.21
Trading Asset Securities
636.3626.15304.69161.24221.77355.34
Cash & Short-Term Investments
1,7141,6761,4061,4271,6991,742
Cash Growth
20.93%19.17%-1.45%-16.03%-2.47%38.93%
Accounts Receivable
356.21527.3458.33542.51413.03367.38
Other Receivables
132.33118.064.3957.589.113.59
Receivables
488.54645.36462.72600.09422.13380.97
Inventory
230.93208.29255.96244.9284.15194.37
Other Current Assets
73.4835.1871.1725.0648.462.1
Total Current Assets
2,5072,5652,1962,2972,4542,380
Property, Plant & Equipment
1,0961,1111,1551,2271,3131,300
Long-Term Investments
148.56296.89299.09132.614.214.2
Goodwill
5.75.75.75.75.75.7
Other Intangible Assets
136.39141.55153.56168.28178.36166.55
Long-Term Deferred Tax Assets
10.1310.29.338.5311.358.83
Long-Term Deferred Charges
97.33102.44117.04125.76128.816.79
Other Long-Term Assets
298.46---0.030.04
Total Assets
4,3004,2323,9363,9654,0963,882
Accounts Payable
87.3191.55201.38133.92180.2491.56
Accrued Expenses
14.36184.85160.61160.45123.86101.77
Short-Term Debt
378.5325.26274.2140.01251.68150.08
Current Portion of Long-Term Debt
84.66103.3104.54107.5733.046.31
Current Portion of Leases
-14.7214.7211.819.529.81
Current Income Taxes Payable
50.9938.6325.9571.7938.1327.17
Current Unearned Revenue
23.8498.0675.99170.01132.79163.65
Other Current Liabilities
162.0839.1136.4551.3859.9838.97
Total Current Liabilities
801.72995.46893.83846.94829.23589.31
Long-Term Debt
144.58121.573.92128.03226.93233.35
Long-Term Leases
28.1728.8660.9578.4587.935.14
Long-Term Unearned Revenue
66.9863.1589.0497.85111.2294.9
Long-Term Deferred Tax Liabilities
0.080.15-0.330.730.58
Other Long-Term Liabilities
13.3213.321.34---
Total Liabilities
1,0551,2221,1191,1521,256923.27
Common Stock
587.57587.57587.57587.57590.2590.2
Additional Paid-In Capital
672.09672.09669.24638.76685.78690.25
Retained Earnings
1,9611,7811,5831,5731,7671,884
Treasury Stock
-----204-204
Comprehensive Income & Other
24.49-31.12-22.7214.130.64-1.14
Shareholders' Equity
3,2453,0102,8172,8132,8402,959
Total Liabilities & Equity
4,3004,2323,9363,9654,0963,882
Total Debt
635.9593.63528.33465.88609.1404.68
Net Cash (Debt)
1,0781,082877.86961.071,0901,338
Net Cash Growth
19.51%23.27%-8.66%-11.86%-18.50%34.86%
Net Cash Per Share
1.861.851.501.631.902.32
Filing Date Shares Outstanding
587.57587.57587.57587.57575.27575.27
Total Common Shares Outstanding
587.57587.57587.57587.57575.27575.27
Working Capital
1,7051,5691,3021,4501,6251,791
Book Value Per Share
5.525.124.794.794.945.14
Tangible Book Value
3,1032,8632,6582,6392,6562,787
Tangible Book Value Per Share
5.284.874.524.494.624.84
Buildings
-1,000993.15997.121,0531,029
Machinery
-773.59775.0676.8676.54563.54
Construction In Progress
-69.5421.2461.66105.26299.65
Source: S&P Global Market Intelligence. Standard template. Financial Sources.